全氟丁烷超声造影诊断甲状腺乳头状癌小侧颈淋巴结转移
该单中心前瞻性研究纳入135例甲状腺乳头状癌患者共161枚短径≤8mm的可疑侧颈淋巴结,使用全氟丁烷超声造影评估血管相和血管后相。
要点
- 血管后相非等增强(低增强、部分增强、无增强)可基本排除小侧颈淋巴结转移。
- 联合血管后相与常规超声特征可显著提高诊断效能(AUC 0.94 vs 0.73)。
- 血管相灌注缺损对转移淋巴结的特异度高达96%。
核心结论
- 全氟丁烷超声造影血管后相在诊断甲状腺乳头状癌患者可疑小侧颈淋巴结转移中表现出优异性能。
研究设计与样本
- 单中心前瞻性研究,连续纳入2020年10月至2021年10月确诊甲状腺乳头状癌且超声发现可疑淋巴结的参与者。
- 共评估135例参与者(中位年龄36岁,IQR 30-46岁;100例女性)的161枚可疑淋巴结,包括67枚转移和94枚良性。
- 所有参与者在活检或手术前1周接受全氟丁烷超声造影,血管相为注射后5-60秒,血管后相为注射后10-30分钟。
- 参考标准为淋巴结的细胞学和组织病理学评估。
关键影像表现/征象
- 血管相灌注缺损作为超声特征的特异度达96%(90/94枚淋巴结)。
- 血管后相非等增强(即低增强、部分增强和无增强)的阴性预测值达100%(83/83枚淋巴结)。
诊断标准与关键数值
- 血管相灌注缺损用于诊断转移淋巴结的特异度为96%。
- 血管后相非等增强的阴性预测值为100%。
临床应用与阅片要点
- 对甲状腺乳头状癌患者短径≤8mm的可疑侧颈淋巴结,可结合超声造影血管后相非等增强表现提高排除转移的信心。
- 联合血管后相与常规超声特征可提升诊断效能,减少不必要的活检或手术。
局限性
- 单中心研究,可能存在选择偏倚。
- 样本量有限,结果需多中心验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Although metastasis of lateral cervical lymph nodes (LNs) is common in papillary thyroid carcinoma (PTC), correctly diagnosing small metastatic LNs with US remains challenging. The use of contrast-enhanced US (CEUS), especially the postvascular phase of CEUS with perfluorobutane contrast material, might contribute to improved diagnosis of metastatic LNs in PTC. Purpose To assess the diagnostic value of the postvascular phase of CEUS with perfluorobutane in suspicious small lateral cervical LNs (short-axis diameter ≤8 mm) in patients with PTC. Materials and Methods This single-center study prospectively enrolled consecutive participants with confirmed PTC and suspicious LNs at US from October 2020 to October 2021. All participants underwent CEUS, 1 week before biopsy or surgery, with intravenous perfluorobutane contrast material to visualize the LNs in the vascular phase (5-60 seconds after injection) and postvascular phase (10-30 minutes after injection). The reference standard was cytologic and surgical histologic assessment of the LNs. The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of sonographic features were calculated, and the diagnostic performance of US, CEUS, and the combination of postvascular phase and US features was assessed using multivariable logistic regression models. Results A total of 135 participants (median age, 36 years [IQR, 30-46 years]; 100 women) with 161 suspicious LNs at US were evaluated, including 67 metastatic and 94 benign LNs. The specificity of perfusion defect as a sonographic feature in the vascular phase reached 96% (90 of 94 LNs), and the negative predictive value of non-isoenhancement (ie, hypoenhancement, partial enhancement, and no enhancement) in the postvascular phase reached 100% (83 of 83 LNs). The area under the receiver operating characteristic curve (AUC) of the combination of postvascular phase and US features was 0.94 (95% CI: 0.89, 0.97), significantly higher than that of US features alone (AUC, 0.73; 95% CI: 0.65, 0.79; P < .001). Conclusion The postvascular phase of CEUS with perfluorobutane demonstrated excellent performance for diagnosing suspicious small lateral cervical LNs in participants with PTC. Published under a CC BY 4.0 license Supplemental material is available for this article. See also the editorial by Gunabushanam in this issue.
引用
- Xiao, Zhou, Tan, et al. Contrast-enhanced US with Perfluorobutane to Diagnose Small Lateral Cervical Lymph Node Metastases of Papillary Thyroid Carcinoma. Radiology. 2023. PMID: 37014242. doi:10.1148/radiol.221465
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。